Try it
Ophthalmology · Glaucoma: low-tension drug effect
Sample itemWhich topical antiglaucoma drug lowers IOP by inhibiting carbonic anhydrase in the ciliary body?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. Dorzolamide
Topical dorzolamide and brinzolamide inhibit carbonic anhydrase in the ciliary body and lower aqueous production. They may cause stinging, bitter taste and rarely sulfonamide-like allergy.
Option by option
A. Brimonidine
Brimonidine is an alpha-2 agonist.
B. Pilocarpine
Pilocarpine acts on trabecular outflow.
C. Dorzolamide (correct)
Correct. Dorzolamide is a topical carbonic anhydrase inhibitor.
D. Latanoprost
Latanoprost acts through uveoscleral outflow.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Ophthalmology questions
- GlaucomaWhich topical glaucoma medicine lowers intraocular pressure mainly by increasing uveoscl…
- Ocular oncologyA 2-year-old child has a white pupillary reflex (leukocoria). The gene commonly involved…
- UveaA patient has a painful red eye with photophobia, ciliary congestion, a small irregular…
- GlaucomaWhich drug is given systemically to reduce intraocular pressure in acute angle-closure g…